Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Ozempic pricing is based on Novo Nordisks publicly listed self-pay costs: $499 a month for an existing patient 2 mg-dose pen and $349 a month for lower-dose pens (0.25 mg, 0.5 mg or 1 mg)
Stimulant-free, caffeine-free weight support with GLP-1inspired appetite control
Functionality, Nutrition, and Product Innovation GLP-1 meal replacement manufacturers are prioritizing: High-protein and nutrient-dense formulations Portion-controlled and lower-sugar meal solutions Digestive-support and satiety-support blends Multi-format product offerings across RTDs, powders, bars, and savory formats Functional nutrition designed specifically for reduced-appetite routines Innovation is increasingly focused on balancing convenience, tolerance, nutritional relevance, and taste appeal
Lotiglipron is an oral, non-peptide GLP-1 receptor agonist that showed therapeutic potential in early clinical trials
US$ 24.78
US$ 29.08
US$ 28.23
